Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C12H11NO3S |
| Molecular Weight | 249.286 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OS(=O)(=O)C1=CC=C(NC2=CC=CC=C2)C=C1
InChI
InChIKey=HYKDWGUFDOYDGV-UHFFFAOYSA-N
InChI=1S/C12H11NO3S/c14-17(15,16)12-8-6-11(7-9-12)13-10-4-2-1-3-5-10/h1-9,13H,(H,14,15,16)
| Molecular Formula | C12H11NO3S |
| Molecular Weight | 249.286 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Quenching of the electrochemiluminescence of tris(2,2'-bipyridine)-ruthenium(II) by sodium diphenylamine-4-sulfonate. | 2009-06 |
|
| Structure-based discovery of triphenylmethane derivatives as inhibitors of hepatitis C virus helicase. | 2009-05-14 |
|
| S-Benzyl-thiouronium 4-anilinobenzene-sulfonate. | 2008-08-30 |
|
| Synthesis and characterization of processable multi-walled carbon nanotubes-sulfonated polydiphenylamine graft copolymers. | 2007-10 |
|
| Facile synthesis and optimization of conductive copolymer nanoparticles and nanocomposite films from aniline with sulfodiphenylamine. | 2006-02-01 |
|
| Structural and ionization effects on the adsorption behaviors of some anilinic compounds from aqueous solution onto high-area carbon-cloth. | 2005-04-11 |
|
| [Study on the inclusion interaction of water-soluble p-(N,N-dimethylamino)-calix[8]arene with diphenylamine-4-sulfonic sodium salt]. | 2005-04 |
|
| In-situ spectroelectrochemical evidences for the copolymerization of o-toluidine with diphenylamine-4-sulphonic acid by UV-visible spectroscopy. | 2002-01-01 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 21:21:17 GMT 2025
by
admin
on
Mon Mar 31 21:21:17 GMT 2025
|
| Record UNII |
6E5XPH8BY9
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
73722
Created by
admin on Mon Mar 31 21:21:17 GMT 2025 , Edited by admin on Mon Mar 31 21:21:17 GMT 2025
|
PRIMARY | |||
|
101-57-5
Created by
admin on Mon Mar 31 21:21:17 GMT 2025 , Edited by admin on Mon Mar 31 21:21:17 GMT 2025
|
PRIMARY | |||
|
6E5XPH8BY9
Created by
admin on Mon Mar 31 21:21:17 GMT 2025 , Edited by admin on Mon Mar 31 21:21:17 GMT 2025
|
PRIMARY | |||
|
m8693
Created by
admin on Mon Mar 31 21:21:17 GMT 2025 , Edited by admin on Mon Mar 31 21:21:17 GMT 2025
|
PRIMARY | Merck Index | ||
|
DTXSID1059234
Created by
admin on Mon Mar 31 21:21:17 GMT 2025 , Edited by admin on Mon Mar 31 21:21:17 GMT 2025
|
PRIMARY | |||
|
202-955-0
Created by
admin on Mon Mar 31 21:21:17 GMT 2025 , Edited by admin on Mon Mar 31 21:21:17 GMT 2025
|
PRIMARY | |||
|
66866
Created by
admin on Mon Mar 31 21:21:17 GMT 2025 , Edited by admin on Mon Mar 31 21:21:17 GMT 2025
|
PRIMARY | |||
|
163911
Created by
admin on Mon Mar 31 21:21:17 GMT 2025 , Edited by admin on Mon Mar 31 21:21:17 GMT 2025
|
PRIMARY |